Afficher la notice abrégée

dc.contributor.authorGómez Cuadrado, Laura
dc.contributor.authorTracey, Natasha
dc.contributor.authorMa, Ruoyu
dc.contributor.authorQian, Binzhi
dc.contributor.authorBrunton, Valerie G.
dc.date.accessioned2024-12-17T11:00:39Z
dc.date.available2024-12-17T11:00:39Z
dc.date.issued2017-09
dc.identifier.issn1754-8403
dc.identifier.urihttp://hdl.handle.net/10259/9793
dc.description.abstractMetastasis is the spread of cancer cells from a primary tumor to distant sites within the body to establish secondary tumors. Although this is an inefficient process, the consequences are devastating as metastatic disease accounts for >90% of cancer-related deaths. The formation of metastases is the result of a series of events that allow cancer cells to escape from the primary site, survive in the lymphatic system or blood vessels, extravasate and grow at distant sites. The metastatic capacity of a tumor is determined by genetic and epigenetic changes within the cancer cells as well as contributions from cells in the tumor microenvironment. Mouse models have proven to be an important tool for unraveling the complex interactions involved in the metastatic cascade and delineating its many stages. Here, we critically appraise the strengths and weaknesses of the current mouse models and highlight the recent advances that have been made using these models in our understanding of metastasis. We also discuss the use of these models for testing potential therapies and the challenges associated with the translation of these findings into the provision of new and effective treatments for cancer patients.en
dc.description.sponsorshipL.G.-C. is supported by a Cancer Research UK Edinburgh Centre training grant (C157/A25186). N.T. is funded by a Medical Research Council (MRC) training grant (MR/K50080X/1). R.M. is partially funded by a University of Edinburgh Global Research Scholarship. B.Q. is partially funded by a Cancer Research UK Career Development Fellowship (C49791/A17367) and a European Research Council Starting Grant (716379). Part of the work was undertaken in the MRC Centre for Reproductive Health, which is funded by a MRC Centre grant (MR/N022556/1). V.G.B. is partially funded by Cancer Research UK (C157/A15703) and the European Research Council (29440)es
dc.format.mimetypeapplication/pdf
dc.language.isoenges
dc.publisherThe Company of Biologistses
dc.relation.ispartofDisease Models & Mechanisms. 2017, V. 10, n. 9, p. 1061-1074es
dc.rightsAttribution 3.0 Unported*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/*
dc.subjectCanceren
dc.subjectMetastasisen
dc.subjectMouse modelsen
dc.subjectStromaen
dc.subject.otherOncologíaes
dc.subject.otherOncologyen
dc.subject.otherSaludes
dc.subject.otherHealthen
dc.titleMouse models of metastasis: progress and prospectsen
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.relation.publisherversionhttps://doi.org/10.1242/dmm.030403es
dc.identifier.doi10.1242/dmm.030403
dc.identifier.essn1754-8411
dc.journal.titleDisease Models & Mechanismses
dc.volume.number10es
dc.issue.number9es
dc.page.initial1061es
dc.page.final1074es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée